Ultrasonic nebulisers for pulmonary drug delivery

International Journal of Pharmaceutics

Volumn 153, Issue 1, 1997, Pages 93-104

  Taylor, Kevin M G ^a   McCallion, Orla N M ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b University of Bath   (United Kingdom)

Author keywords

Aerosol; Drug delivery; Formulation; Nebuliser; Particle size; Ultrasonic

Indexed keywords

EXCIPIENT; LIPOSOME; MACROGOL 8000; POLYSORBATE 20; POLYSORBATE 80; PRESERVATIVE; PROPYLENE GLYCOL; SORBITAN TRIOLEATE; SURFACTANT;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUTION; NEBULIZER; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SURFACE TENSION; TEMPERATURE; ULTRASOUND; VISCOSITY;

EID: 0030790542     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00105-1     Document Type: Article

References (60)

1. Atkins, P.J., Barker N.P., Mathisen, D., 1992. The design and development of inhalation drug delivery systems. In: Hickey, A.J. (Ed.) Pharmaceutical Inhalation Aerosol Technology, Marcel Dekker, New York, pp. 155-185.
2. Baker, P.G., Stimpson, P.G., 1994. Electronically controlled drug delivery systems based on the piezo electric crystal. Respir. Drug Delivery 4, 273-285.
3. Ballard, R.D., Bogin, R.M., Pak, J., 1991. Assessment of bronchodilator response to a β-adrenergic delivered from an ultrasonic nebulizer. Chest 100, 410-415.
4. Barber, R.F., Shek, P.N., 1989. Liposome stability during ultrasonic nebulization. Proceedings of the Thirty Third Harden Conference, The Biochemical Society, Ashford, UK, p. 53.
5. 99mTc-DTPA in the human respiratory tract. Int. J. Pharm. 102, 159-165.
6. Beasley, R., Rafferty, P., Holgate, S.T., 1988. Adverse reactions to the non-drug constituents of nebuliser solutions. Br. J. Clin. Pharmacol. 25, 283-287.
7. Boguslavskii, Y.Y., Eknadiosyants, O.K., 1969. Physical mechanism of the acoustic atomization of a liquid. Sov. Phys. Acoust. 15, 14-21.
8. Boucher, R.M.G., Kreuter, J., 1968. The fundamentals of the ultrasonic atomization of medicated solutions. Ann. Allergy 26, 591-600.
9. British National Formulary, 1996. No. 32, British Medical Association and Royal Pharmaceutical Society of Great Britain, London, p. 147.
10. Cipolla, D.C., Clark, A.R., Chan, H.-K., Gonda, I., Shire, S.J., 1994. Assessment of aerosol delivery systems for recombinant human deoxyribonuclease STP. Pharma Sci. 4, 50-62.
11. Clay, M.M., Pavia, D., Newman, S.P., Lennard-Jones, T., Clarke, S.W., 1983. Assessment of jet nebulisers for lung aerosol therapy. Lancet 2, 592-594.
12. Dennis, J.H., Hendrick, D.J., 1992. Design characteristics for drug nebulizers. J. Med. Eng. Technol. 16, 63-68.
13. Farr, S.J., Kellaway, I.W., Parry-Jones, D.R., Woolfrey, S.G., 1985. 99m-Technetium as a marker of liposomal deposition and clearance in the human lung. Int. J. Pharm. 26, 303-316.
14. Ferron, G.A., Kerrebijn, K.F., Weber, J., 1976. Properties of aerosols produced with three nebulizers. Am. Rev. Respir. Dis. 114, 899-908.
15. Flament, M.-P., Leterme, P., Gayot, A.T., 1995. Factors influencing nebulizing efficiency. Drug Dev. Ind. Pharm. 21, 2263-2285.
16. Gershenzon, E.L., Eknadiosyants, O.K., 1964. The nature of liquid atomization in an ultrasonic fountain. Sov. Phys. Acoust. 10, 156-162.
17. Greenspan, B.J., 1996. Ultrasonic and electrohydrodynamic methods of aerosol generation. In: Hickey, A.J. (Ed.) Inhalation Aerosols: Physical and Biological Basis for Therapy, Marcel Dekker, New York, pp. 313-335.
18. Herzog, P., Norlander, O.P., Engström, C.-G., 1964. Ultrasonic generation of aerosol for the humidification of inspired gas during volume controlled ventilation. Acta Anaesth. Scand. 8, 79-95.
19. Il'in, B.I., Eknadiosyants, O.K., 1966. Nature of liquid atomization in an ultrasonic fountain. Sov. Phys. Acoust. 12, 310-318.
20. Ip, A.Y., Arakawa, T., Silvers, H., Ransone, C.M., Niven, R.W., 1995. Stability of recombinant consensus interferon to air-jet and ultrasonic nebulization. J. Pharm. Sci. 84, 1210-1214.
21. Istiman, A.T., Manoli, R., Schmidt, G.H., Holmes, R.A., 1974. An assessment of alveolar deposition and pulmonary clearance of radiopharmaceuticals after nebulization. Am. J. Roentgenol. 120, 776-781.
22. Lewis, R.A., 1983. Nebulisers for lung aerosol therapy. Lancet 2, 849.
23. Lin, M.S., Hayes, T.M., Goodwin, D.A., Kruse, S.L., 1974. Distal penetration in radioaerosol inhalation with an ultrasonic nebulizer. Radiology 112, 443-447.
24. Kapustina, O.A., 1969. Effect of surface active substances on bubble growth kinetics in a sound field. Sov. Phys. Acoust. 15, 110-111.
25. Lang, R.J., 1962. Ultrasonic atomization of liquids. J. Acoust. Soc. Am. 34, 6-8.
26. Leung, K.K.M., Bridges, P.A., Taylor, K.M.G., 1996. The stability of liposomes to ultrasonic nebulisation. Int. J. Pharm. 145, 95-102.
27. Lobdell, D.D., 1968. Particle size-amplitude reactions for the ultrasonic atomizer. J. Acoust. Soc. Am. 43, 229-231.
28. McCallion, O.N.M., Taylor, K.M.G., Thomas, M., Taylor, A.J., 1995. Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers. Pharm. Res. 12, 1682-1688.
29. McCallion, O.N.M., Taylor, K.M.G., Bridges, P.A., Thomas, M., Taylor, A.J., 1996a. Jet nebulisers for pulmonary drug delivery. Int. J. Pharm. 130, 1-11.
30. McCallion, O.N.M., Taylor, K.M.G., Thomas, M., Taylor, A.J., 1996b. The influence of surface tension on aerosols produced by medical nebulisers. Int. J. Pharm. 129, 123-136.
31. McCallion, O.N.M., Taylor, K.M.G., Thomas, M., Taylor, A.J., 1996c. Nebulisation of monodisperse latex sphere suspensions in air-jet and ultrasonic nebulisers. Int. J. Pharm. 133, 203-214.
32. Mercer, T.T., 1981. Production of therapeutic aerosols: principles and techniques. Chest 80, 813-817.
33. Mercer, T.T., Goddard, R.F., Flores, R.L., 1968. Output characteristics of three ultrasonic nebulizers. Ann. Allergy 26, 18-27.
34. Newman, S.P., Clarke, S.W., 1983. Therapeutic aerosols. I. Physical and practical considerations. Thorax 38, 881-886.
35. Newman, S.P., Woodman, G., Clarke, S.W., 1988. Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. Thorax 43, 318-322.
36. Newman, S.P., Pellow, P.G.D., Clarke, S.W., 1987. In vitro comparison of DeVilbiss jet and ultrasonic nebulizers. Chest 92, 991-994.
37. Niven, R.W., 1996. Atomization and nebulisers. In: Hickey, A.J. (Ed.) Inhalation Aerosols: Physical and Biological Basis for Therapy, Marcel Dekker, New York, pp. 273-312.
38. Niven, R.W., Schreier, H., 1990. Nebulization of liposomes I. Effects of lipid composition. Pharm. Res. 7, 1127-1133.
39. Niven, R.W., Ip, A.Y., Mittelman, S., Prestrelski, S.J., Arakawa, T., 1995. Some factors associated with the ultrasonic nebulization of proteins. Pharm. Res. 12, 53-59.
40. Pallares, D.E., Pilarski, B.R., Rodriguez, J.L., Leickly, F.E., 1996. A comparison of bronchodilator responses to albuterol delivered by ultrasonic versus jet nebulization in moderate to severe asthma. Ann. Allergy Asthma Immun. 77, 292-297.
41. Phipps, P.R., Gonda, I., 1990. Droplets produced by medical nebulizers: some factors affecting their size and solute concentration. Chest 97, 1327-1332.
42. Rhoades, E.R., Ringrose, R., Mohr, J.A., Brooks, L., McKown, B.A., Felton, F., 1971. Contamination of ultrasonic nebulization equipment with Gram negative bacteria. Arch. Intern. Med. 127, 228-232.
43. Ryan, G., Dolovich, M.B., Obminski, G., Cockcroft, D.W., Juniper, E., Hargreave, F.E., Newhouse, M.T., 1981. Standardization of inhalation provocation tests: influence of nebulizer output, particle size and method of inhalation. J. Allergy Clin. Immunol. 67, 156-161.
44. Schöni, M.H., Kraemer, R., 1989. Osmolarity changes in nebulizer solutions. Eur. Respir. J. 2, 887-892.
45. Smalldone, G.C., Perry, R.J., Deutsch, D.G., 1988. Characteristics of nebulizers used in the treatment of AIDS-related Pneumocystis carinii pneumonia. J. Aerosol Med. 1, 113-126.
46. Sollner, K., 1936. The mechanism of the formation of fogs by ultrasonic waves. Trans. Faraday Soc. 32, 1532-1536.
47. Stahlhofen, W., Gebhart, J., Heyder, J., 1980. Experimental determination of the regional deposition of aerosol particles in the human respiratory tract. Am. Ind. Hyg. Assoc. J. 41, 385-398.
48. Sterk, P.J., Plomp, A., Van der Vate, J.F., Quanjer, P.H., 1984. Physical properties of aerosols produced by several jet and ultrasonic nebulizers. Bull. Eur. Physiopathol. Respir. 20, 65-72.
49. Taylor, K.M.G., Farr, S.J., 1993. Liposomes for drug delivery to the respiratory tract. Drug Dev. Ind. Pharm. 19, 123-142.
50. Taylor, K.M.G., Hoare, C., 1993. Ultrasonic nebulisation of pentamidine isethionate. Int. J. Pharm. 98, 45-49.
51. Taylor, K.M.G., Taylor, G., Kellaway, I.W., Stevens, J., 1989. The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man. Pharm. Res. 6, 633-636.
52. Taylor, K.M.G., Taylor, G., Kellaway, I.W., Stevens, J., 1990. The stability of liposomes to nebulisation. Int. J. Pharm. 58, 57-61.
53. Taylor, K.M.G., Venthoye, G., Chawla, A., 1992. Pentamidine isethionate delivery from jet nebulisers. Int. J. Pharm. 85, 203-208.
54. Thomas, S.H.L., O'Doherty, M.J., Page, C.J., Nunan, T.O., Bateman, N.T., 1991. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers. Eur. Respir. J. 4, 616-622.
55. Tovell, R.M., D'Ambruoso, D.C., 1962. Humidity in inhalation therapy. Anaesthesiology 23, 452-459.
56. 99mtechnetium labelled beclomethasone dipropionate dilaurylphosphatidylcholine liposome aerosol in normal volunteers. Int. J. Pharm. 115, 209-216.
57. Waldman, D.L., Weber, D.A., Oberdörster, G., Drago, S.R., Utell, M.J., Hyde, R.W., Morrow, P.E., 1987. Chemical breakdown of technetium-99m DTPA during nebulization. J. Nucl. Med. 28, 378-382.
58. Weast, R.C. (Ed.), 1988a. Handbook of Chemistry and Physics, 69th ed. CRC Press, Boca Raton, p. F-34.
59. Weast, R.C. (Ed.), 1988b. Handbook of Chemistry and Physics, 69th ed. CRC Press, Boca Raton, p. F-40.
60. Zierenberg, B., 1992. The Respimat, a new inhalation system based on the piezoelectric effect. J. Biopharmaceut. Sci. 3, 85-90.